Efficacy of lenalidomide in multiple myeloma and myelodysplastic syndrome with deletion of 5q in a patient with pre-existing MGUS

被引:0
|
作者
Mueller, N. Z. [1 ]
Nolte, F. [1 ]
Kreil, S. [1 ]
Hofmann, W-K [1 ]
Metzgeroth, G. [1 ]
机构
[1] Univ Med Mannheim, Med Klin 3, Mannheim, Germany
来源
ONKOLOGIE | 2012年 / 35卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:149 / 150
页数:2
相关论文
共 50 条
  • [1] Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
    List, Alan
    Dewald, Gordon
    Bennett, John
    Giagounidis, Aristotle
    Raza, Azra
    Feldman, Eric
    Powell, Bayard
    Greenberg, Peter
    Thomas, Deborah
    Stone, Richard
    Reeder, Craig
    Wride, Kenton
    Patin, John
    Schmidt, Michele
    Zeldis, Jerome
    Knight, Robert
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1456 - 1465
  • [2] Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion
    Duong, Vu H.
    Komrokji, Rami S.
    List, Alan F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (02) : 105 - 116
  • [3] Cryptic 5q deletion in a patient with myelodysplastic syndrome
    Medlock, Ruth
    Barrans, Sharon
    Cargo, Catherine
    Kelly, Richard
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (03) : 347 - 347
  • [4] Efficacy of lenalidomide for treatment of anemia in secondary myelodysplastic syndrome (MDS) with chromosome 5q deletion
    Mintzer, David Michael
    Billet, Shira N.
    BLOOD, 2007, 110 (11) : 226B - 226B
  • [5] Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts
    Serin, Istemi
    Eren, Rafet
    Dogu, Mehmet Hilmi
    JOURNAL OF HEMATOLOGY, 2020, 9 (1-2) : 33 - 36
  • [6] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
  • [7] 5q deletion myelodysplastic syndrome
    Chari, Preethi S.
    Chander, Smitha
    Sundareshan, T. S.
    Prasad, Sujay
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (02) : 301 - +
  • [8] Azacitidine Treatment of Lenalidomide-Resistant Myelodysplastic Syndrome with Deletion 5q
    Komrokji, Rami S.
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 1195 - 1195
  • [9] 5q Deletion Myelodysplastic Syndrome a Young Male Patient
    Elkattawy, Sherif
    Ayad, Sarah
    El-Feki, Iman
    Guo, Xutong
    Appiah-Kubi, Edmund
    Talpur, Afrah
    Kessler, William
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [10] Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
    Mahmoud R. Gaballa
    Emmanuel C. Besa
    Annals of Hematology, 2014, 93 : 723 - 733